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RESEARCH ARTICLE Open Access
High-intensity interval training and β-hydroxy-
β-methylbutyric free acid improves aerobic power
and metabolic thresholds
Edward H Robinson IV1,2†, Jeffrey R Stout1,2*†, Amelia A Miramonti1,2†, David H Fukuda1,2†, Ran Wang1,2†,
Jeremy R Townsend1,2†, Gerald T Mangine1,2†, Maren S Fragala1,2† and Jay R Hoffman1,2†
Abstract
Background: Previous research combining Calcium β-hydroxy-β-methylbutyrate (CaHMB) and running high-intensity
interval training (HIIT) have shown positive effects on aerobic performance measures. The purpose of this study was to
examine the effect of β-hydroxy-β-methylbutyric free acid (HMBFA) and cycle ergometry HIIT on maximal oxygen
consumption (VO2peak), ventilatory threshold (VT), respiratory compensation point (RCP) and time to exhaustion
(Tmax) in college-aged men and women.
Methods: Thirty-four healthy men and women (Age: 22.7 ± 3.1 yrs ; VO2peak: 39.3 ± 5.0 ml · kg−1 · min−1) volunteered
to participate in this double-blind, placebo-controlled design study. All participants completed a series of tests prior to
and following treatment. A peak oxygen consumption test was performed on a cycle ergometer to assess VO2peak,
Tmax, VT, and RCP. Twenty-six participants were randomly assigned into either a placebo (PLA-HIIT) or 3 g per day of
HMBFA (BetaTor™) (HMBFA-HIIT) group. Eight participants served as controls (CTL). Participants in the HIIT groups
completed 12 HIIT (80-120% maximal workload) exercise sessions consisting of 5–6 bouts of a 2:1 minute cycling
work to rest ratio protocol over a four-week period. Body composition was measured with dual energy x-ray
absorptiometry (DEXA). Outcomes were assessed by ANCOVA with posttest means adjusted for pretest differences.
Results: The HMBFA-HIIT intervention showed significant (p < 0.05) gains in VO2peak, and VT, versus the CTL and
PLA-HIIT group. Both PLA-HIIT and HMBFA-HIIT treatment groups demonstrated significant (p < 0.05) improvement
over CTL for Tmax, and RCP with no significant difference between the treatment groups. There were no significant
differences observed for any measures of body composition. An independent-samples t-test confirmed that there were
no significant differences between the training volumes for the PLA-HIIT and HMBFA-HIIT groups.
Conclusions: Our findings support the use of HIIT in combination with HMBFA to improve aerobic fitness in college
age men and women. These data suggest that the addition of HMBFA supplementation may result in greater changes
in VO2peak and VT than HIIT alone.
Study registration: The study was registered on ClinicalTrials.gov (ID NCT01941368).
Keywords: High-intensity interval training, β-Hydroxy-β-Methylbutyric free acid, Aerobic, Endurance, VO2peak,
Respiratory compensation point, Ventilatory threshold
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Background
High-intensity interval training (HIIT) has become a popu-
lar training modality in competitive athletes, recreationally-
trained individuals, and clinical populations [1]. HIIT
consists of repeated bouts of short to moderate dur-
ation exercise completed at intensities greater than the
anaerobic threshold, interspersed with brief periods of low
intensity or passive rest. The salient features of HIIT over
constant rate aerobic training (CRT) are shorter training
periods and the reported improvements of both oxidative
and glycolytic energy systems [1,2].
Physiological adaptations associated with HIIT include
improved metabolic efficiency [3,4] related to a more ef-
ficient skeletal muscle substrate utilization, and im-
proved respiratory control sensitivity resulting from
increased mitochondrial density [5]. Helgerud et al. [6]
reported that an eight-week running HIIT program im-
proved VO2max and time to exhaustion (TTE) more
than CRT in moderately trained males. Further, Smith
et al. [7] reported a 7% to 10% increase in VO2peak and
ventilatory threshold (VT) values after only 3 weeks of
HIIT on a cycle ergometer using college age males.
HIIT, therefore, is a time-efficient exercise strategy that
has shown consistent positive results following relatively
short duration training programs.
The branched-chain amino acid, leucine, has shown to be
the key contributor for muscle protein synthesis and may
play a role as a substrate during this process [8]. As such,
dietary supplementation of leucine and its metabolites has
been demonstrated to provide anabolic or anti-catabolic
effects on lean body mass during training or periods of en-
ergy imbalance [9-11]. Ingestion of one of these metabo-
lites, β-hydroxy-β-methylbutyrate in the free acid form
(HMBFA), has been suggested to provide similar benefits to
those of leucine with regard to muscle protein synthesis
[12]. Additional investigation with CaHMB and resistance
training in humans has shown improvement in muscle
mass and strength in both younger and older subjects
[13-16]. Recently, scientists have suggested CaHMB may
enhance the benefits of intense aerobic training by attenuat-
ing skeletal muscle damage and accelerating recovery
between training bouts. In support, Knitter et al. [17] exam-
ined the effect of three grams of CaHMB or placebo per
day in trained endurance athletes for six weeks. Following
the training and supplementation period, blood markers of
muscle damage, creatine phosphokinase (CPK) and lactate
dehydrogenase (LDH), were measured in response to a
20-km race. Following the race, LDH and CPK levels were
10.5% and 17% lower in the CaHMB supplemented group,
respectively compared to the placebo group. These results
[17] suggest that CaHMB supplementation may attenuate
some of the muscle damage often observed with endurance
training, possibly reducing the incidence of overtraining
and allowing for greater training adaptations.
Ingestion of CaHMB during an aerobic training pro-
gram appears to provide additional benefits. Vukovich
and Dreifort [18] examined the effect of 3 grams of
CaHMB or placebo per day for 14 days in elite cyclists
while average training volume was 300 miles per week.
In response to only the CaHMB condition, the cyclists
demonstrated a significant increase in peak oxygen con-
sumption rate (VO2peak) and an increase in the onset of
blood lactate accumulation during a graded exercise test.
Those investigators suggested that changes in maximal
and submaximal performance following CaHMB supple-
mentation may have been related to both the attenuation
of protein breakdown and the augmentation of mito-
chondrial protein synthesis resulting in greater oxidative
energy capacity. In further support, Lamboley et al. [19]
examined the effect of 5 weeks of CaHMB supplementa-
tion and HIIT in physically-active college students. They
measured changes in VO2max, VT and respiratory com-
pensation point (RCP) during a graded exercise test at
baseline and post training. The HIIT running program
was performed 3 times per week on a treadmill (1%
grade) and participants supplemented with 3 grams per
day of CaHMB or placebo. The results of the investiga-
tion demonstrated significant increases in VO2max, VT
and RCP in both treatment groups from the HIIT; how-
ever, the CaHMB group resulted in a 19% to 45% greater
increase in all metabolic variables. The investigators’
suggested that CaHMB may have attenuated the muscle
damage often observed from running and might have ac-
celerated recovery between training bouts. Further, CaHMB
supplementation may have enhanced the training stimulus
of HIIT on VT and RCP by increasing mitochondrial
biogenesis, thus improving oxidative energy capacity
and efficiency [13,18,19].
It appears that HMBFA supplementation is most effect-
ive during muscle damaging exercise [20]. Lamboley et al.
[19] indicated that they specifically selected running to in-
duce delayed onset muscle soreness, a non-invasive indi-
cator of muscle damage. However, to date, no one has
examined the effect of HMBFA supplementation while
undergoing a HIIT program on a cycle ergometer. If
muscle damage is needed to observe the potential benefits
of HMBFA supplementation, then HIIT training on a cycle
ergometer, which produces much less muscle damage [21]
than running, may provide no additional benefit. There-
fore, the purpose of this study was to examine the effects
of chronic (4-weeks) HMBFA supplementation in combin-
ation with cycle ergometry HIIT on endurance perform-
ance measures in active college age men and women.
Methods
Participants
For inclusion in the study, all males were required to
have a VO2peak greater than 35 ml∙kg
−1∙min−1 and all
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female participants greater than 30 ml∙kg−1∙min−1. After
initial testing, forty recreationally-active individuals
(men = 21, women = 19) between the ages of 18 and 35
were recruited to participate in this study. Three female
and two male participants were removed due to health
reasons not associated with the study. One female par-
ticipant was removed after a family emergency. There-
fore, data for 19 men and 15 women (Table 1) were
included in the final analysis. All participants completed
a questionnaire to assess ability to participate in physical
activity and to ascertain any prior supplementation re-
gime. Individuals self-reported to be free of musculoskel-
etal injury as determined by a physical activity readiness
questionnaire (PAR-Q). Following an explanation of all
procedures, risks and benefits, each participant provided
his/her informed consent to participate in the study.
A minimum sample size of n = 8 per group was deter-
mined using previously published data [19] and the for-
mula derived by Gravettier and Wallnau [22] to achieve
a statistical power (1-β) of 0.80. Therefore, with an expect-
ation of subject dropout, a final sample size of n = 15 in
each experimental group and n = 10 in the control group
were recruited. The study was registered on ClinicalTrials.
gov (ID NCT01941368).
Research design
A double-blind, placebo-controlled design, stratified for
gender, was used to examine the effects of HMBFA and
HIIT training on measures of metabolic performance.
Each participant was required to visit the Human Per-
formance Laboratory on four separate occasions for
pre- and post- testing, with each testing session occur-
ring on nonconsecutive days. The same testing proto-
cols were repeated at the beginning and end of the 4-week
training period. On the first testing day, anthropometric
measures of participants were collected (Table 1). Each
participant then performed a graded exercise test to
determine peak oxygen consumption (VO2peak), time
to exhaustion (Tmax), respiratory compensation point
(RCP), and ventilatory threshold (VT). The peak wattage
achieved during this test was used to establish individual
training intensity. On the second day of testing, a baseline
blood draw was performed to measure serum HMB, and
total lean soft tissue (TLST) and body fat percentage (BF)
were assessed using dual energy x-ray absorptiometry
(DEXA) (Prodigy™; Lunar Corporation, Madison, WI,
USA).
After baseline testing, the participants were randomly
assigned to one of three groups: a control group (CTL),
a placebo with HIIT group (PLA-HIIT) or HMBFA with
HIIT group (HMBFA-HIIT). Of the 40 subjects that
were recruited for this study, 10 subjects were assigned
to CTL and 15 to each of the training groups (PLA-HIIT
or HMBFA-HIIT).
Exercise protocol
Participants in the PLA-HIIT and HMBFA-HIIT groups
participated in 4-weeks of high-intensity interval training
with three sessions per week—with at least one day be-
tween each training session—on a calibrated, electronically-
braked cycle ergometer (Lode Corival 400, Groningen, the
Netherlands). The exercise training program consisted of
alternating training sessions of sub-maximal and supra-
maximal workloads (Figure 1). Each participant’s training
load was determined as a percentage of the peak power
output (Ppeak) from the graded exercise test. Individuals
began each training session with a 5-minute warm up at a
self-selected wattage, followed by an exercise protocol of
five 2-minute exercise bouts at a predetermined percentage
of their power output at VO2peak. Between each exercise
bout, the participant had 1 minute of complete rest. In the
event that there was an inability to complete the entire 2-
min exercise bout, the participant completed the 1-min rest
period and attempted subsequent bouts. Total time com-
pleted and power output was recorded for each exercise
session to calculate total training volume (Power output
(Watts) × Total time =Training Volume). Participants
assigned to CTL were asked to continue their normal activ-
ity pattern for 4 weeks before returning to undergo post-
testing.
Supplementation
The HMBFA supplement consisted of 1 gram of β-
hydroxy-β-methylbutyrate in the free acid form (Beta-
Tor™, Metabolic Technologies Inc, Ames, IA), reverse
osmosis water, de-bittering agent, orange flavor, stevia
Table 1 Participant descriptive statistics
Variable Control (n = 8) PLA-HIIT (n = 13) HMBFA-HIIT (n = 13) p-value
Age (y) 21.0 ± 2.4 23.6 ± 3.7 22.9 ± 2.4 0.166
Height (cm) 171.4 ± 5.7 172.6 ± 12.2 173.0 ± 9.2 0.939
Body mass (kg) 76.3 ± 12.8 74.9 ± 16.6 72.4 ± 9.9 0.793
% Body fat 22.4 ± 8.1 19.7 ± 8.6 24.8 ± 8.1 0.301
Training volume (kJ) N/A 1437.0 ± 309.6 1456.8 ± 378.6 0.313
Values are presented as means ± SD. HIIT, high-intensity interval training. HMBFA, β-hydroxy-β-methylbutyrate in the free acid form (BetaTor™, Metabolic Technologies
Inc, Ames, IA), PLA, placebo.
Robinson et al. Journal of the International Society of Sports Nutrition 2014, 11:16 Page 3 of 11
http://www.jissn.com/content/11/1/16
extract, and potassium carbonate. Each serving of pla-
cebo contained 1 gram of polydextrose that was equiva-
lent to β-hydroxy-β-methylbutyrate in the free acid, citric
acid, corn syrup, stevia extract, de-bittering agent, and
orange flavoring. Identical in appearance and taste, the
HMBFA and PL treatments were produced and supplied
by Metabolic Technologies Inc. (Ames, IA). Prior to the
first training session, subjects were randomly assigned to
receive either 3 g per day of HMBFA or a placebo divided
equally into three servings, given 30 minutes prior to
exercise and again 1 hour later and then a final 1 g dose
3 hours post exercise on training days. To ensure compli-
ance, investigators watched as the subjects consumed the
supplement prior to and immediately after each exercise
session. On the non-training days, subjects were instruc-
ted to consume one packet with three separate meals
throughout the day. Empty packets were presented to the
investigators upon returning to the laboratory following
non-training days.
Blood measurements and HMB analysis
During testing days, resting blood samples were drawn
following a 15-min equilibration period. These blood sam-
ples were obtained from an antecubital arm vein using a
20-gauge disposable needle equipped with a Vacutainer®
tube holder (Becton Dickinson, Franklin Lakes, NJ) con-
taining K2EDTA. Each participant’s blood samples were
obtained at the same time of day during each testing ses-
sion. The blood was centrifuged at 3,000 × g for 15 min
along and the resulting plasma was placed into s 1.8-mL
microcentrifuge tube and frozen at −80°C for later analysis.
Plasma HMB concentrations were analyzed by gas
chromatography–mass spectrometry which was per-
formed by Metabolic Technologies Inc. in a blinded
fashion using methods previously described by Nissen
et al. [23].
Dietary analysis
Prior to training, participants were asked to complete a
3-day food log, to establish macronutrient content and
average leucine intake. This diet was considered the par-
ticipant’s standard diet and they were asked to maintain
a similar regimen throughout the duration of the study.
These data were entered into a software program (Food
Works 13, The Nutrition Company; Long Valley, NJ)
which provided calculation for daily leucine intake (g)
and total calories (kcal).
Determination of VO2peak, VT, and RCP
An incremental test to volitional exhaustion was per-
formed on an electronically-braked cycle ergometer
(Lode Excalibur Sport; Groningen, The Netherlands) to de-
termine VO2peak and the Ppeak in watts (W) at VO2peak.
Prior to testing, each participant was fitted with a Polar
Heart Watch system to record the participants’ heart rate
(Polar Electro Inc., Lake Success, NY). Following the pro-
cedures described by Bergstrom et al. [24], participants
were instructed to maintain a pedaling cadence of 70–75
revolutions per minute (RPM) at an initial workload of
75 W. The workload increased 25 W every two minutes
until he or she was unable to maintain a cadence above 70
RPM for ~10s despite verbal encouragement, or volitional
fatigue. Prior to each graded exercise test, open-circuit
spirometry (TrueOne 2400® Metabolic Measurement
System, Parvo Medics, Inc., Sandy, UT) was calibrated
with room air and gases of known concentration, which
was used to estimate VO2peak (ml∙kg
−1∙min−1) by sam-
pling and analyzing breath-by-breath expired gases.
Oxygen (O2), carbon dioxide (CO2), ventilation (VE),
and respiratory exchange ratio (RER)—were monitored
continuously and expressed as 30-second averages [25].
VO2peak was determined to be the highest 30-s VO2
value during the test and coincided with at least two of
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Figure 1 Exercise training intensity protocol.
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the following three criteria: (a) 90% of age-predicted max-
imum heart rate; (b) respiratory exchange ratio > 1.1; and/
or (c) a plateau of oxygen uptake (less than 150 mL/min
increase in VO2 during the last 60 s of the test). The test-
retest reliability for VO2peak was ICC = 0.96 (SEM =
1.4 ml.kg.min−1).
Ventilatory threshold (VT) and RCP were determined
by common methods for determining gas exchange
thresholds [26-29]. The VT was determined by plotting
and determining the point of increase in the VE/VO2
versus VO2 curve as the VE/VCO2 versus VO2 curve
remained constant or decreased [24,26]. The RCP as
described by Beaver et al. [26] was identified using the V-
Slope method by plotting the VE versus VCO2. The VT and
RCP were reported as the corresponding VO2 and power
output in watts (PVT and PRCP). The test-retest reliability
for VT and RCP was ICC = 0.97 (SEM 0.1 ml.kg.min−1)
and 0.87 (SEM 0.2 ml.kg.min−1), respectively.
Anthropometric measures
Body composition was estimated from a scan by DEXA
(GE Medical Systems Lunar, Madison, WI, USA; soft-
ware version 13.60.033) performed by a state licensed
x-ray technician. Participants were positioned supine in
the center of the platform and were scanned using the
default scan mode for total body scanning. Measures
for total lean soft tissue (LSTM) and fat mass were cal-
culated by the system software (Encore 2011, software
version 13.60.033). Body composition was analyzed
using estimated body fat percentage (%BF) and total
lean soft tissue mass (LSTM). The test-retest reliability
for LSTM and% BF was ICC = 0.99 (SEM 0.4 kg) and
0.99 (SEM 0.8%BF), respectively.
Statistical analyses
Statistical software (IBM SPSS Statistics for Windows,
Version 21.0; Armonk, NY: IBM Corp) was used to per-
form all statistical analysis. Separate one-way analyses of
covariance (ANCOVA) were used to analyze all dependent
performance and metabolic variable data based on the
recommendations of Huck and McLean [30]. The inde-
pendent variable, group, included 3 levels: PLA-HIIT,
HMBFA-HIIT, and CTL. The pretest and posttest values
were used as the covariate and dependent variable, re-
spectively. When appropriate, LSD post hoc pairwise
comparisons were used to examine the differences among
the groups. For effect size, the partial eta squared statistic
was calculated, and according to Green et al. [31], 0.01,
0.06, and 0.14 were interpreted as small, medium, and
large effect sizes, respectively. Two-way ANOVA (Time ×
treatment) was used to examine changes in plasma HMB
concentration between PLA-HIIT and HMBFA-HIIT.
Independent-samples t-tests’ were performed to compare
total training volume, total energy and leucine intake for
the PLA-HIIT and HMBFA-HIIT groups. An alpha of
p < 0.05 was established a priori.
Results
The pre- and post-intervention mean and standard devi-
ations for all metabolic and performance measures
(VO2peak, Ppeak, Tmax, RCP, PRCP, VT, and PVT) for all
groups (CTL, PLA-HIIT, HMBFA-HIIT) are provided in
Table 2. Table 3 provides the group mean and standard
deviations for pre- to post-intervention body compos-
ition measures (BW, LSTM, and BF).
Peak oxygen uptake (VO2peak)
The ANCOVA indicated a significant difference (p = 0.003,
η2 = 0.322) among the group means for the posttest
VO2peak values after adjusting for pre-test differences
(Figure 2). The strength of the association (i.e., effect
size, η2) indicated that the treatment groups (CTL,
PLA-HIIT, HMBFA-HIIT) accounted for 32% of the
variance of the post-test VO2peak values, holding con-
stant the pre-test VO2peak scores. The LSD pairwise
comparisons indicated that the increase in VO2peak
from pre- to post-testing was greater for the HMBFA-
HIIT group than for the CTL (p = 0.001) and the PLA-
HIIT groups (p = 0.032), however, no differences were
found between PLA-HIIT and CTL groups (p = 0.09).
The group means (±SEM) for the post-test VO2peak
values, adjusted for initial differences in pre-test scores,
are shown in Figure 2.
Peak power (Ppeak)
The ANCOVA indicated a significant difference (p = 0.013,
η2 = 0.251) among the group means for the post-test Ppeak
values after adjusting for pre-test differences (Figure 3).
The strength of the association (i.e., effect size, η2)
indicated that the treatment groups (CTL, PLA-HIIT,
HMBFA-HIIT) accounted for 25% of the variance of the
post-test Ppeak values, holding constant the pre-test Ppeak
scores. The LSD pairwise comparisons indicated that the
increase in Ppeak from pre- to post-testing was greater for
the HMBFA-HIIT (p = 0.04) and PLA-HIIT (p = 0.018)
groups than for the CTL group, however, no differences
were found between HMBFA-HIIT and PLA-HIIT groups
(p = 0.51). The group means (±SEM) for the post-test Ppeak
values, adjusted for initial differences in pre-test scores, are
shown in Figure 3.
Time to exhaustion (Tmax)
The ANCOVA indicated a significant difference (p = 0.002,
η2 = 0.35) among the group means for the post-test Tmax
values after adjusting for pre-test differences (Figure 4).
The strength of the association (i.e., effect size, η2) indi-
cated that the treatment groups (CTL, PLA-HIIT,
HMBFA-HIIT) accounted for 35% of the variance of
Robinson et al. Journal of the International Society of Sports Nutrition 2014, 11:16 Page 5 of 11
http://www.jissn.com/content/11/1/16
the post-test Tmax values, holding constant the pre-test
Tmax scores. The LSD pairwise comparisons indicated
that the increase in Tmax from pre- to post-testing was
greater for the HMBFA-HIIT (p = 0.001) and PLA-HIIT
(p = 0.002) groups than for the CTL group, however, no
differences were found between HMBFA-HIIT and
PLA-HIIT groups (p = 0.62). The group means (±SEM)
for the post-test Tmax values, adjusted for initial differ-
ences in pretest scores, are shown in Figure 4.
Respiratory Compensation Point (RCP)
The ANCOVA indicated a significant difference (p < 0.001,
η2 = 0.436) among the group means for the posttest RCP
values after adjusting for pre-test differences (Figure 5).
The strength of the association (i.e., effect size, η2) indi-
cated that the treatment groups (CTL, PLA-HIIT,
HMBFA-HIIT) accounted for 44% of the variance of
the post-test RCP values, holding constant the pre-test
RCP scores. The LSD pairwise comparisons indicated
that the increase in RCP from pre- to post-testing was
greater for the HMBFA-HIIT (p < 0.001) and PLA-HIIT
(p < 0.001) groups than for the CTL group, however, no
differences were found between HMBFA-HIIT and
PLA-HIIT groups (p = 0.77). The group means (±SEM)
for the posttest RCP values, adjusted for initial differ-
ences in pretest scores, are shown in Figure 5.
Power at Respiratory Compensation Point (PRCP)
The ANCOVA indicated a significant difference (p = 0.001,
η2 = 0.375) among the group means for the posttest PRCP
values after adjusting for pre-test differences (Table 2,
Figure 6). The strength of the association (i.e., effect
size, η2) indicated that the treatment groups (CTL,
PLA-HIIT, HMBFA-HIIT) accounted for 38% of the
variance of the post-test PRCP values, holding constant
the pre-test PRCP scores. The LSD pairwise compari-
sons indicated that the increase in PRCP from pre- to
post-testing was greater for the HMBFA-HIIT (p < 0.001)
and PLA-HIIT (p < 0.001) groups than for the CTL group,
however, no differences were found between HMBFA-
HIIT and PLA-HIIT groups (p = 0.97). The group means
(±SEM) for the posttest PRCP values, adjusted for initial
differences in pretest scores, are shown in Figure 6.
Ventilatory Threshold (VT)
The ANCOVA indicated a significant difference (p = 0.016,
η2 = 0.24) among the group means for the post-test VT
values after adjusting for pre-test differences (Figure 7).
The strength of the association (i.e., effect size, η2) indi-
cated that the treatment groups (CTL, PLA-HIIT,
HMBFA-HIIT) accounted for 24% of the variance of
the posttest VT values, holding constant the pre-test
VT scores. The LSD pairwise comparisons indicated
that the increase in VT from pre- to post-testing was
Table 2 Metabolic and performance measures for pre- and post-supplementation
Control (n = 8) PLA-HIIT (n = 13) HMBFA-HIIT (n = 13)
Measure Pretest Posttest Pretest Posttest Pretest Posttest
VO2peak (ml · kg
−1 · min−1) 39.1 ± 4.5 38.9 ± 4.0 38.9 ± 3.4 40.3 ± 2.6 39.8 ± 6.7 42.7 ± 5.1
Ppeak (W) 218.8 ± 41.7 215.6 ± 32.6 221.2 ± 46.6 236.5 ± 48.5 226.9 ± 56.3 246.2 ± 54.8
Tmax (min) 12.5 ± 2.9 12.2 ± 2.3 13.0 ± 3.8 14.2 ± 3.7 13.6 ± 4.7 14.9 ± 4.5
RCP (ml · kg−1 · min−1) 30.5 ± 5.0 28.7 ± 2.7 29.3 ± 3.1 31.9 ± 2.2 32.2 ± 4.2 33.7 ± 3.8
PRCP (W) 175.3 ± 38.8 167.0 ± 24.8 168.4 ± 36.0 185.0 ± 33.5 182.6 ± 33.6 196.5 ± 35.1
VT (ml · kg−1 · min−1) 27.7 ± 3.3 27.2 ± 2.7 28.6 ± 3.1 29.0 ± 4.1 27.8 ± 4.8 31.7 ± 3.7
PVT (W) 156.3 ± 17.7 153.1 ± 28.2 159.6 ± 40.2 169.2 ± 37.0 161.5 ± 39.02 184.6 ± 37.6
Values are means ± SD. HIIT, high-intensity interval training; HMBFA, β-hydroxy-β-methylbutyrate in the free acid form (BetaTor™, Metabolic Technologies Inc,
Ames, IA); PLA, placebo; VO2peak, peak oxygen uptake; Ppeak, peak power achieved; Tmax, time to exhaustion during graded exercise test; RCP, respiratory-
compensation point; VT, ventilatory threshold.
Table 3 Body composition measures for pre- and post-supplementation
Control (n = 8) PLA-HIIT (n = 13) HMBFA-HIIT (n = 13)
Measure Pretest Posttest Pretest Posttest Pretest Posttest
Body weight (kg) 76.3 ± 12.8 75.5 ± 12.7 74.9 ± 16.6 75.2 ± 16.3 72.4 ± 9.9 72.5 ± 10.0
Lean soft tissue mass (kg) 56.5 ± 11.7 56.4 ± 10.7 58.4 ± 16.6 58.6 ± 16.6 52.2 ± 10.9 52.2 ± 10.9
Total body fat mass (kg) 15.9 ± 7.0 14.3 ± 8.4 13.3 ± 4.8 13.2 ± 4.6 16.9 ± 5.3 17.0 ± 5.4
Body fat % 22.4 ± 8.1 22.0 ± 2.8 19.7 ± 8.6 19.5 ± 8.4 24.8 ± 8.1 24.6 ± 7.7
Values are means ± SD. HIIT, high-intensity interval training; HMBFA, β-hydroxy-β-methylbutyrate in the free acid form (BetaTor™, Metabolic Technologies Inc,
Ames, IA); PLA, placebo.
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greater for the HMBFA-HIIT group than for the CTL
(p = 0.012) and the PLA-HIIT groups (p = 0.017), how-
ever, no differences were found between PLA-HIIT and
CTL groups (p = 0.6). The group means (±SEM) for the
posttest VT values, adjusted for initial differences in
pretest scores, are shown in Figure 7.
Power at Ventilatory Threshold (PVT)
The ANCOVA indicated a significant difference (p = 0.009,
η2 = 0.267) among the group means for the post-test PVT
values after adjusting for pre-test differences (Figure 8).
The strength of the association (i.e., effect size, η2) indi-
cated that the treatment groups (CTL, PLA-HIIT,
HMBFA-HIIT) accounted for 27% of the variance of
the post-test PVT values, holding constant the pre-test
PVT scores. The LSD pairwise comparisons indicated
that the increase in PVT from pre- to post-testing was
greater for the HMBFA-HIIT group than for the CTL
(p = 0.004) and the PLA-HIIT groups (p = 0.027), how-
ever, no differences were found between PLA-HIIT and
CTL groups (p = 0.277). The group means (±SEM) for
the posttest PVT values, adjusted for initial differences
in pretest scores, are shown in Figure 8.
Body composition
The ANCOVA indicated no significant difference for body
mass (p = 0.31, η2 = 0.074) percent body fat (p = 0.88, η2 =
0.009), and lean soft tissue mass (p = 0.247, η2 = 0.089) be-
tween the groups (Table 3).
Training volume
There was no significant difference (p = 0.31) between
training volumes for PLA-HIIT (1437.0 ± 309.6 kJ) and
HMBFA-HIIT (1456.8 ± 378.6 kJ).
Dietary analysis
There was no significant difference for daily energy intake
(p = 0.159; PLA-HIIT, 2398.7 ± 619 Kcal; HMBFA-HIIT,
2011 ± 620 Kcal) or leucine intake (p = 0.561; PLA-HIIT,
3.3 ± 1.7 g; HMBFA-HIIT, 3.9 ± 2.1 g) between the two
treatment groups.
Supplementation compliance and plasma HMBFA
concentrations
Placebo or HMBFA intake was recorded on individual
intake logs, which were returned to the laboratory and
monitored and resulted in 99% compliance. In addition,
there was a significant interaction (F = 5.9, p = 0.02) for
blood plasma HMBFA concentrations. The HMBFA-
HIIT group increased by 2.6 ± 2.1 nmol∙ml−1 with little
change in the PLA-HIIT group (0.1 ± 0.9 nmol∙ml−1),
further supporting compliance in the treatment group.
Figure 2 VO2peak obtained during graded exercise test. Mean
values (+SEM) for posttest VO2peak scores adjusted for the initial
differences in pretest VO2peak (covariate; adjusted pretest mean = 39.3).
*HMBFA-HIIT significantly greater than PLA-HIIT (p = 0.032) and
CTL (p = 0.001).
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Figure 3 Peak power (Ppeak) obtained during graded exercise test. Mean values (+SEM) for posttest Ppeak scores adjusted for the initial
differences in pretest Ppeak (covariate; adjusted pretest mean = 222.79). *Indicates significantly different than CTL (PLA-HIIT, p = 0.018; HMBFA-HIIT, p= 0.04).
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Discussion
To the best of our knowledge, this is the first study to
examine the effects of the free-acid form of β-hydroxy-
β-methylbutyrate (HMB) supplementation and high-
intensity interval training (HIIT) using a cycle ergometer
on metabolic and performance measures in young men
and women. The primary findings support the use of
HIIT in combination HMBFA as a training method to
improve aerobic fitness. Furthermore, the results of the
current study suggest that HMBFA supplementation sig-
nificantly improved the benefits of the 4-week HIIT pro-
gram on VO2peak, VT and PVT aerobic and metabolic
measures when compared to HIIT alone.
The HIIT protocol used in the current study (Figure 1)
resulted in a 4 to 11% increase in aerobic performance
measures (VO2peak, Ppeak, Tmax; Table 2). This is
consistent with Smith et al. [7] who reported a 7% to
11% increase in VO2peak and Tmax after 3 weeks of HIIT
using a similar protocol. In agreement, several other stud-
ies have reported 7 to 10% increases in VO2peak using
HIIT protocols in college-aged participants [6,32,33]. Al-
though previous studies utilizing this method of HIIT uti-
lized a 5-day per week training routine, Jourkesh et al. [34]
also reported a significant increase in Tmax after 3 weeks
of periodized HIIT and a significant increase in VO2peak
after 6 weeks with training 3 times per week.
In the current investigation, the addition of HMBFA in-
gestion with HIIT significantly (7.3%) increased VO2peak
(Table 2, Figure 2) greater than training alone. The present
results are in agreement with Lamboley et al. [19] who re-
ported a 15% increase in VO2max after 5 weeks of a run-
ning HIIT program while supplementing with 3 grams per
day of calcium β-hydroxy-β-methylbutyrate (CaHMB) in
college age men and women. In contrast, previous studies,
which involved supplementation of CaHMB while endur-
ance training, found no increase in VO2peak with 2 to
6 weeks of supplementation [17,18]. In a cross-over de-
sign, Vukovich and Dreifort [18], examined the effect of
CaHMB supplementation in endurance-trained cyclists,
and reported no significant increase in VO2peak in these
highly trained athletes, however, there was a significant in-
crease (3.6%) in the time to reach VO2peak (Tmax). The
increase in Tmax observed by Vukovich and Dreifort [18],
was smaller than our observed 8% increase in younger un-
trained men and women (Table 2). The discrepancy be-
tween our study and the previous endurance training
studies [18] examining CaHMB could be due to the train-
ing experience of the participants used in the investiga-
tion. It has been suggested that active men and women
who are unaccustomed to HIIT may benefit more from
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Figure 4 Time to exhaustion (Tmax) for the graded exercise test. Mean values (+SEM) for posttest Tmax scores adjusted for the initial differences in
pretest Tmax (covariate; adjusted pretest mean = 13.11). *Indicates significantly different than CTL (PLA-HIIT, p = 0.002; HMBFA-HIIT, p = 0.001).
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Figure 5 Respiratory compensation point (RCP). Mean values
(+SEM) for posttest RCP scores adjusted for the initial differences in
pretest RCP (covariate; adjusted pretest mean = 30.69). *Indicates
significantly different than CTL (PLA-HIIT, p < 0.001; HMBFA-HIIT,
p < 0.001).
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CaHMB supplementation than trained athletes who are
accustomed to HIIT [19]. The participants in the current
study were unfamiliar with HIIT, which may explain why
our results were similar to Lamboley et al. [19] and not
Vukovich et al. [18] who used trained endurance athletes.
However, Knitter et al. [17] also examined individuals un-
accustomed to HIIT, but reported no additive effect of
HMB supplement on endurance performance measures.
Therefore, training status and previous experience with
HIIT could have influenced the current results while
explaining differences from previous investigations.
The differences reported by Lamboley et al. [19] and
our findings versus other studies may be due to the fact
that individualized HIIT programs were developed based
on each participant’s baseline fitness level and monitored
throughout the 28 days of training, while it was unclear
what endurance program was used in other studies [18].
Therefore, the difference in results by Knitter [17] and
Vukovich et al. [18] in comparison to Lamboley et al.
[19] and our data may be related to an insufficient train-
ing stimulus that was unable to stimulate physiological
adaptation [13,20,35].
Fatigue threshold measures, such as VT, RCP, and on-
set of blood lactate accumulation (OBLA), have been
used as non-invasive measures of health and perform-
ance, and in the evaluation of the efficacy of endurance
training and/or nutritional supplementation [19,36,37].
Further, the measurement of specific fatigue thresholds
during a graded exercise test, like VT and RCP, may be
useful for demarcating the heavy or severe exercise in-
tensity domains, respectively [24]. For example, VT has
been associated with the minimum exercise intensity
that results in excessive CO2 production from the bicar-
bonate buffering of hydrogen ions [38,39], while exercise
above RCP has been associated with the severe intensity
domain which leads to excessive minute ventilation
resulting from hyperkalemia [24,40]. The measurement
of fatigue thresholds (VT, RCP), therefore, may provide
possible mechanistic explanation for aerobic perform-
ance changes from training or nutritional interventions.
Additionally, assessment of the exercise intensity domains,
heavy (VT), severe (RCP) and maximal (VO2peak), during
a graded exercise test may improve the sensitivity of de-
tecting the potential effects on aerobic performance from
various exercise and or nutritional interventions due to
different mechanisms.
In the current study, the four-week HIIT program re-
sulted in a 6.3% increase in power output at ventilatory
threshold (PVT) (Table 2) which is similar to Smith et al.
[7] who reported a ~9% increase using a comparable
three-week HIIT cycling protocol in untrained college
aged men. In addition, our study demonstrated an 8.6%
increase in RCP which was very similar to the changes
reported by Lamboley et al. [19] of an 8.5% increase
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Figure 7 Ventilatory Threshold (VT). Mean values (+SEM) for
posttest VT scores adjusted for the initial differences in pretest VT
(covariate; adjusted pretest mean = 28.68). *HMBFA-HIIT significantly
greater than PLA-HIIT (p = 0.017) and CTL (p = 0.012).
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Figure 8 Power at ventilatory threshold (PVT). Mean values
(+SEM) for posttest PVT scores adjusted for the initial differences in
pretest PVT (covariate; adjusted pretest mean = 160.29). *HMBFA-HIIT
significantly greater than PLA-HIIT (p = 0.027) and CTL (p = 0.004).
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Figure 6 Power at respiratory compensation point (PRCP).
Mean values (+SEM) for posttest PRCP scores adjusted for the initial
differences in pretest PRCP (covariate; adjusted pretest mean = 175.43).
*Indicates significantly different than CTL (PLA-HIIT, p = 0.001; HMBFA-
HIIT, p = 0.001).
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from 5 weeks of HIIT on a treadmill. Our data, along
with Smith et al. [7] and Lamboley et al. [19], support
previous studies that demonstrate HIIT consistently im-
proves metabolic threshold measures [6,41,42].
The addition of HMBFA to the four weeks of HIIT
(HMB-HIIT) resulted in a ~14% increase in VT which was
significantly greater than HIIT alone (Table 2, Figure 7).
However, there was no difference between HMBFA-HIIT
and PLA-HIIT groups for changes in RCP (Table 2,
Figure 5). While our changes in VT are similar to
values reported by Lamboley et al. [19], they described
no significant difference between CaHMB-HIIT and
PLA-HIIT groups. However, Lamboley et al. [19] reported
significantly greater changes in RCP for CaHMB-HIIT
compared to PLA-HIIT, whereas the current investigation
resulted in similar changes between groups. Furthermore,
Vukovich and Dreifort [18] reported a 9.1% increase in
OBLA after two weeks of CaHMB supplementation in
elite cyclists. Previous researchers have used OBLA as a
method to identify the crossover point between moderate
to heavy exercise intensities denoted by blood lactate con-
centrations greater than 4 mmol∙L−1 during an incremen-
tal exercise test [43]. With previous evidence supporting
OBLA and VT as fatigue thresholds representing similar
exercise domains, the increases in exercise intensity at
OBLA (+9.1%) reported by Vukovich and Dreifort [18]
and the increase in VT (+14%) observed in our study
(Table 2) may reflect similar physiological adaptations.
Our results, along with Vukovich and Dreifort [18] and
Lamboley et al. [19], suggest that HMBFA may augment
the beneficial effects of HIIT on aerobic performance by
increasing fatigue threshold measures that reflect the
physiological response to moderate and/or severe intensity
exercise.
The physiological changes observed in aerobic perform-
ance from HIIT have been shown to improve VO2peak,
muscle buffering capacity, and whole body fat oxidation
[1,44,45]. Further, the improved aerobic power associated
with HIIT has been linked to an up-regulation of glyco-
lytic enzymes, as well as, increased mitochondrial density
and blood flow [46,47]. HMBFA supplementation may im-
prove HIIT training by up-regulating fatty acid oxidation,
adenosine monophosphate kinase (AMPK), Sirt1, and
Sirt3 activity in muscle cells [48,49]. Sirt1, Sirt3, and
AMPK have been shown to augment mitochondrial bio-
genesis, lipolysis, energy metabolism and the reactive oxy-
gen defense system [50,51]. Additionally, Pinheiro et al.
[49] reported that 28 days of CaHMB administration in
male Wistar rats resulted in significantly increased intra-
muscular ATP and glycogen content. While speculative,
HMBFA supplementation may have enhanced the effects
of HIIT by improving mitochondrial biogenesis, fat oxida-
tion, and metabolism. However, more research is needed
to support these proposed mechanisms in humans.
Conclusions
In conclusion, our findings support the use of HIIT in
combination with HMBFA as an effective training stimu-
lus for improving aerobic performance. In addition, the
use of HMBFA supplementation, in combination with
HIIT, appeared to result in greater changes in VO2peak,
PVT and VT than HIIT alone. While more research is
needed, the current investigation suggests that in this
sample of college age men and women, the use of
HMBFA supplementation may enhance the benefits of
HIIT on aerobic performance measures.
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